These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5940860)

  • 21. [Vaccination against measles].
    Flugsrud L
    Tidsskr Nor Laegeforen; 1971 Jan; 91(2):132-4. PubMed ID: 5539604
    [No Abstract]   [Full Text] [Related]  

  • 22. Unusual clinical reactions to live measles vaccine in a child previously immunized with killed measles vaccine.
    Iwai T; Matumoto M; Kawana R
    Jpn J Exp Med; 1968 Apr; 38(2):139-42. PubMed ID: 5304930
    [No Abstract]   [Full Text] [Related]  

  • 23. [Measles in the Local Health Unit Naples 4: vaccination coverage, epidemic 2001-2002 and prevention strategies].
    Gigli L; Graziano M; Manetta G; Palombino R
    Ann Ig; 2004; 16(5):627-32. PubMed ID: 15552728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Measles immunization and its problems].
    Kökkaya A
    Mikrobiyol Bul; 1982 Jan; 16(1):66-70. PubMed ID: 7144618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mass vaccination against measles in Chile with Enders attenuated virus vaccine].
    Ristori C; Boccardo H; Borgoño JM; Miranda M
    Bol Oficina Sanit Panam; 1966 May; 60(5):396-400. PubMed ID: 4222614
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and immunological study of a group of children vaccinated against measles and exposed afterwards to natural measles].
    Rodriguez Rouanet E
    Rev Col Med Guatem; 1965 Dec; 16(4):210-3. PubMed ID: 5885685
    [No Abstract]   [Full Text] [Related]  

  • 27. [Vaccination against measles].
    Ek E
    Tidsskr Nor Laegeforen; 1971 Jan; 91(2):135-7. PubMed ID: 5539605
    [No Abstract]   [Full Text] [Related]  

  • 28. [Measles. 5 years' experience with the vaccination program in Chile].
    Borgoño JM; Greiber R
    Rev Med Chil; 1971 Jul; 99(7):500-6. PubMed ID: 5093511
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experiences with the live measles vaccine].
    Vivell O; Lips G
    Arch Kinderheilkd; 1967; 176(2):156-63. PubMed ID: 5592896
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combined measles-smallpox vaccination].
    Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Ramírez A; Guzmán E
    Bol Oficina Sanit Panam; 1969 Oct; 67(4):322-7. PubMed ID: 4242000
    [No Abstract]   [Full Text] [Related]  

  • 31. A Bellagio consensus. Children's Vaccine Initiative Ad Hoc Committe on an Investment Strategy for Measles Control.
    J Infect Dis; 1994 Nov; 170 Suppl 1():S63-6. PubMed ID: 7930755
    [No Abstract]   [Full Text] [Related]  

  • 32. Measles vaccination and risk of SSPE.
    Agarwal RK
    Indian Pediatr; 1999 Mar; 36(3):317. PubMed ID: 10713848
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles vaccination: a review.
    Oberman JW
    GP; 1967 May; 35(5):106-7. PubMed ID: 6046507
    [No Abstract]   [Full Text] [Related]  

  • 34. [Measles-rubella vaccination campaign].
    Infirm Fr; 1984 Jan; (251):23-6. PubMed ID: 6561159
    [No Abstract]   [Full Text] [Related]  

  • 35. [Development and evolution of an antimeasles vaccine].
    Weibel RE
    Bol Oficina Sanit Panam; 1974 Aug; 77(2):135-40. PubMed ID: 4277803
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sex-specific differences in mortality after high-titre measles vaccination].
    Bouvier-Colle MH
    Rev Epidemiol Sante Publique; 1995; 43(1):97. PubMed ID: 7892522
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mass vaccination campaign against measles in Africa].
    Labusquiere R
    Med Trop (Mars); 1966; 26(5):483-96. PubMed ID: 6009275
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience with vaccination against measles in Czech regions].
    Adam E; Domoráková E; Kratochvílová M; Burian V; Janotová J; Drevo M; Verhun V; Doubková S; Hartl J
    Cesk Pediatr; 1970 Sep; 25(9):438-40. PubMed ID: 5455607
    [No Abstract]   [Full Text] [Related]  

  • 39. [Characteristics of the epidemiological process of measles in the period of carrying out the vaccination program].
    Cazacu E; Stefanov I; Roman V; Ulmeanu V; Răducanu S; Vîlceleanu M; Raicu G; Burilescu L; Boţîrlăeanu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1982; 27(3):167-77. PubMed ID: 7156693
    [No Abstract]   [Full Text] [Related]  

  • 40. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
    Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.